Maprotiline in pain-depression.

Abstract	A group of 25 patients treated with maprotiline was studied to test the question of second-generation antidepressant effectiveness in chronic pain. Of this group, 18 (72%) responded with a greater than 50% reduction in their pain syndrome. It appears that maprotiline is as effective as earlier antidepressants in the treatment of pain. The enkephalin induction hypothesis is discussed as an explanation for the mechanism of action of antidepressants in chronic pain.
Authors	P G Lindsay, R B Olsen
Journal	The Journal of clinical psychiatry (J Clin Psychiatry) Vol. 46 Issue 6 Pg. 226-8 (Jun 1985) ISSN: 0160-6689 [Print] United States
PMID	3888970 (Publication Type: Clinical Trial, Journal Article)
Chemical References	Anthracenes Antidepressive Agents Enkephalins Maprotiline
Topics	Adult Aged Anthracenes (therapeutic use) Antidepressive Agents (pharmacology) Brain (drug effects) Chronic Disease Clinical Trials as Topic Depressive Disorder (complications, drug therapy, psychology) Enkephalins (metabolism) Female Humans Male Maprotiline (pharmacology, therapeutic use) Middle Aged Pain (complications, drug therapy, psychology) Stimulation, Chemical

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!